1Post-marketing requirements of the US accelerated approval and European conditional marketing authorization during 2015-2020ZHANG Xiao-fang, BAI Xue, SUN Wan, WANG Feng-zhi, CHEN Si-yu, WU Yang-feng737-7442Preliminary study on the comprehensive protection system of intellectual property of innovative Chinese medicine:based on the empirical analysis of Lianhua Qingwen products manufactured by Yiling PharmaceuticalZHOU Jia, MAO Ji, XUE Jiao, HE Hua-shan745-7513Fezolinetant,a non-hormonal treatment for perimenopausal vasomotor symptomsXIAO Ran, DU Xiao-li752-7554New considerations for the risk-based initiation of drug registration clinical trial inspection from the perspective of regulatory scienceHE Hui, LIU Yi-di, ZHOU Gang756-7605Analysis of consultation on general technical issues in drug registration application in the Guangdong-Hong Kong-Macao Greater Bay AreaLI Lan-lan, TAN Meng-si, HUANG Xiao-long761-7676Evaluation consideration for clinical research and development of URAT1 inhibitors for goutSERI Ge-leng, AI Xing, ZHAO Bo-yuan, LI Yuan-hong, ZHAO Tian, ZHANG Jie768-7737Progress in application of on-line inspection technology in continuous tablet manufacturingLIANG Jun-jie, ZHANG Yao, PAN Hao-min, RAO Xiao-yong, LIU Wei, LUO Xiao-jian, HE Yan774-7848Current status of B-cell targeted therapy in systemic lupus erythematosusQIANG Dan, SUN You785-7919Efficacy and safety of Taizi Shenyue Capsules in the treatment of mild to moderate depressionXU Bao-yan, LIU Yuan-xin, YIN Xiao-li, ZHAO Jing-ping, WU Hai-shan, ZHANG Ke-rang, XIAO Wei-dong, HOU Dong-fen, LIU Ying, LI Cheng-gong, LI Le-hua792-79710Developmental status and considerations of global clinical trial systemsCHANG Feng-yuan, LIN Lin, TIAN Li-juan798-80411Discussion on the issues and solutions in clinical trial design of new traditional Chinese medicines from the perspective of quality controlTAN Qin, LI Qing-na, XIAO Meng-li, YING Jia-ke, ZHAO Meng-jie, JI Jin-jin, LU Fang, QIU Pan-bo805-80912The effect of Lezhe polysaccharide crude extract on inhibiting H2O2-induced oxidative damage in HepG2 cells in vitro and its mechanismFAN Hui-fang, LI Guo-feng, CHEN Hai-fang, ZHANG Wu-gang810-81713Preparation and quality control of four types of serotypes pneumococcal immune serumMA Qing-hua, ZHU Xiang-guo, HUA Chun-hui, YANG Li-meng, ZHENG Jia818-82414Mechanism of proanthocyanidin B2 regulating iron metabolism and reducing oxidative stress to promote myelin regeneration in cuprizone-induced demyelinating modelYUAN Shu-wen, CHEN Ying, LIU Jian, LIANG Ya-jie, LI Yan-qing, CHAI Zhi, XIAO Bao-guo, MA Cun-gen, WANG Qing825-83515Expert consensus and regulatory recommendations on clinical application of daridorexantCHEN Gui-hai, LI Yi, LI Zhi-yu, PAN Ji-yang, WANG Xu-yi, WANG Yu-ping, ZHANG Xiao-chu836-84316Literature analysis of adverse drug reactions induced by baricitinibLIU Li-hua, LI Mei-yun, DING Ling, HU Jian, ZHANG Zi-fan, ZHANG Yu-min844-848 